...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Prostate Cancer Foundation Retreat 2019 - Poster

This must have been just recently posted to the Zenith website. 

Prostate Cancer Foundation Retreat 2019 - Poster

https://www.zenithepigenetics.com/upload/media_element/112/01/zenith-pcf-retreat-2019-poster.pdf

 

Share
New Message
Please login to post a reply